Furthermore, we have used multiple in silico tools to explore the functional effect of the variant, and investigated the mechanisms of BRCA1 loss of heterozygosity (LOH) in ovarian carcinomas occurred in carriers. This evidence concerns the gene BRCA1 and ovarian carcinoma.